Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes-Reference-Cited by-同舟云学术

Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes

Published:2014-02-28 Issue:2 Volume:9 Page:e89561
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kochupurakkal Nora M.,Kruger Annie J.,Tripathi Sudipta,Zhu Bing,Adams La Tonya,Rainbow Daniel B.,Rossini Aldo,Greiner Dale L.,Sayegh Mohamed H.,Wicker Linda S.,Guleria Indira

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion;C Blank;Cancer Immunol Immunother,2007

2. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia;Q Zhou;Blood

3. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction;L Trautmann;Nat Med,2006

4. Mechanisms of PDL1-mediated regulation of autoimmune diabetes;I Guleria;Clin Immunol,2007

5. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal;BT Fife;Nat Immunol,2009

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors-Associated Diabetes and Ketoacidosis Were Found in FDA Adverse Event Reporting System: A Real-World Evidence Database Study;Endocrine Practice;2024-09

2. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use;Endocrine Practice;2024-06

3. Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti–PD-1 Immune Checkpoint Inhibitor Cancer Therapy;The Journal of Immunology;2024-03-01

4. Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review;Frontiers in Public Health;2023-12-01

5. Stocking the toolbox—Using preclinical models to understand the development and treatment of immune checkpoint inhibitor‐induced immune‐related adverse events;Immunological Reviews;2023-08-10